Increased serum levels of OLFM4 have been proposed as diagnostic markers of early stages of gastric cancer and colorectal cancer (Oue et al., 2009; Grover et al., 2010; Seko et al., 2010; Yu et al., 2011a). Here, OLFM4 is linked to gastric cancer.